International Journal of Genomics
Brief Name:
INT J GENOMICS
Impact factor:
2.6 (2023)
ISSN:
2314-436X
Home Page:
Open Access:
Yes
Publisher:
Hindawi Limited
Article Processing Charge:
$2060 USD
Annual Articles:
32
Self-citation Rate:
0.7%
Chinese Academy of Sciences SCI Journal Classification:
| Major category | Ｍinor category | TOP journal | Ｒeview journal |
|---|---|---|---|
Q3 BIOLOGICAL |
BIOCHEMISTRY AND MOLECULAR BIOLOGY | No | No |
Subject Classification:
BIOCHEMISTRY & MOLECULAR BIOLOGY
CiteScore:
| CiteScore | SJR | SNIP | CiteScore ranking | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5.4 | 0.617 | 0.574 |
|
H-Index:
17
SCI Index Status:
Science Citation Index Expanded
Official Review Time:
Submission to first decision:61 days
Submission to acceptance:143 days
PubMed Central:
Submission Site:
Aims and Scope:
International Journal of Genomics is a peer-reviewed, Open Access journal that publishes research articles as well as review articles in all areas of genome-scale analysis. Topics covered by the journal include, but are not limited to: bioinformatics, clinical genomics, disease genomics, epigenomics, evolutionary genomics, functional genomics, genome engineering, and synthetic genomics.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.